Background
Methods
Patient cohort
Surveillance data collection
Recurrence data collection
Relapse risk classification of HCC patients after ablation
Statistical analysis
Results
Stratification of patients by recurrence risk
Characteristics | Value |
---|---|
Patients | 616 |
Pre-TACE | 145 (23.5) |
Age (yrs.) | 56.0 (18.0) |
Male | 556 (90.3) |
Ablation | |
Radiofrequency | 469 (76.1) |
Microwave | 147 (23.9) |
Tumor number | |
Single | 499 (81.0) |
Multiple | 117 (19.0) |
Tumor size (cm) | |
≤ 3 | 473 (76.8) |
> 3 | 143 (23.2) |
Risk area | 159 (25.8) |
AFP ≥200 ng/ml | 187 (30.4) |
Hb (109/L) | 142.0 (22.3) |
PLT (109/L) | 121.0 (90.0) |
RBC (109/L) | 4.6 (0.8) |
WBC (109/L) | 5.2 (2.5) |
ALB (g/L) | 41.5 (6.0) |
ALT (U/L) | 35.2 (26.8) |
AST (U/L) | 33.6 22.57) |
TBIL (μmol/L) | 15.0 (20.4) |
Child-Pugh grade | |
A | 594 (96.4) |
B | 22 (3.6) |
PT (seconds) | 12.3 (1.8) |
Viral hepatitis | 574 (93.2) |
Cirrhosis | 503 (81.7) |
Variable | Recurrence-free survival | |||
---|---|---|---|---|
Univariate | Multivariate | |||
HR (95% CI) |
P
| HR (95% CI) |
P
| |
Age | 1.24 (0.98, 1.56) | 0.068 | 1.19 (0.94, 1.51) | 0.142 |
Male | 0.94 (0.64, 1.36) | 0.732 | ||
Tumor number | 1.47 (1.13, 1.91) | < 0.001 | 1.32 (1.00, 1.73) | 0.048 |
Tumor size | 1.32 (1.18, 1.49) | < 0.001 | 1.26 (1.11, 1.43) | < 0.001 |
Risk area | 1.20 (0.94, 1.53) | 0.138 | ||
AFP ≥200 ng/mL | 1.25 (0.99, 1.57) | 0.067 | 1.25 (0.98, 1.58) | 0.067 |
Pre-TACE | 1.23 (0.96, 1.58) | 0.097 | 1.07 (0.82, 1.40) | 0.606 |
PLT < 100 × 109/L | 1.28 (1.02, 1.60) | 0.032 | 1.18 (0.93, 1.84) | 0.169 |
RBC < 4.3 × 109/L | 1.00 (0.79, 1.26) | 0.975 | ||
WBC < 4.0 × 109/L | 1.20 (0.93, 1.56) | 0.161 | ||
ALB < 35 g/L | 1.48 (1.07, 2.06) | 0.019 | 1.30 (0.92, 1.84) | 0.133 |
ALT < 50 U/L | 1.00 (0.78, 1.28) | 0.990 | ||
AST < 40 U/L | 1.07 (0.85, 1.35) | 0.578 | ||
TBIL > 17.1 μmol/L | 1.01 (0.96, 1.07) | 0.695 | ||
PT > 16.5 s | 0.80 (0.40, 1.63) | 0.545 | ||
Cirrhosis | 1.12 (0.88, 1.57) | 0.263 |
Surveillance patterns
Characteristics | Low risk group | High risk group | ||||
---|---|---|---|---|---|---|
Short interval | Long interval |
P
| Short interval | Long interval |
P
| |
Patients | 199 (75.7) | 64 (24.3) | 145 (79.7) | 37 (20.3) | ||
Pre-TACE | 22 (11.1) | 11 (17.2) | 0.284 | 71 (49.0) | 12 (32.4) | 0.106 |
Age (yrs.) | 55.0 (17.5) | 54.0 (19.5) | 0.962 | 56.0 (14) | 61.0 (21) | 0.058 |
Male | 177 (88.9) | 61 (95.3) | 0.206 | 135 (93.1) | 35 (94.6) | 1.000 |
Tumor number | 1.000 | 0.971 | ||||
Singular | 199 (100.0) | 64 (100.0) | 69 (47.6) | 18 (48.6) | ||
Multiple | – | – | 76 (52.4) | 19 (51.4) | ||
Tumor size | 0.631 | |||||
≤ 3 cm | 199 (100.0) | 64 (100.0) | 34 (37.2) | 16 (43.2) | ||
> 3 cm | – | – | 91 (62.8) | 21 (56.8) | ||
Risk area | 50 (25.1) | 14 (21.9) | 0.719 | 39 (26.9) | 9 (24.3) | 0.914 |
AFP ≥200 ng/ml | 67 (33.7) | 10 (15.6) | 0.009 | 86 (59.3) | 20 (54.1) | 0.695 |
Hb (109/L) | 143.0 (2.80) | 145.5 (19.2) | 0.331 | 142.0 (21.2) | 142.0 (22.1) | 0.367 |
PLT (109/L) | 131.0 (96.0) | 129.5 (95.9) | 0.896 | 105.1 (85.0) | 132.0 (98.0) | 0.452 |
RBC (109/L) | 4.5 (0.8) | 4.8 (0.8) | 0.013 | 4.6 (0.8) | 4.5 (0.9) | 0.556 |
WBC (109/L) | 5.3 (2.5) | 5.4 (2.5) | 0.579 | 5.2 (2.5) | 5.80 (0.9) | 0.357 |
ALB (g/L) | 41.9 (7.9) | 42.5 (5.6) | 0.671 | 41.2 (5.8) | 40.3 (6.7) | 0.804 |
ALT (U/L) | 34.1 (23.4) | 37.2 (29.5) | 0.229 | 37.1 (29.1) | 36.0 (25.3) | 0.773 |
AST (U/L) | 32.3 (20.0) | 33.5 (20.0) | 0.802 | 35.7 (22.3) | 35.5 (28.6) | 0.868 |
TBIL (μmol/L) | 14.4 (9.0) | 15.2 (6.8) | 0.678 | 16.0 (11.8) | 14.3 (5.2) | 0.137 |
Child-Pugh grade | 0.732 | 0.348 | ||||
A | 191 (96.0) | 44 (95.3) | 138 (95.2) | 44 (100.0) | ||
B | 8 (4.0) | 3 (4.7) | 7 (4.80) | 0 (0.00) | ||
PT (seconds) | 12.3 (1.7) | 12.1 (1.6) | 0.135 | 12.3 (1.8) | 12.4 (1.8) | 0.837 |
Viral hepatitis | 184 (92.5) | 59 (92.2) | 1.000 | 137 (94.5) | 34 (91.9) | 0.838 |
Cirrhosis | 159 (79.9) | 51 (79.7) | 1.000 | 125 (86.2) | 26 (70.3) | 0.040 |
Comparison of early recurrence and retreatment
Characteristics | Low risk group | High risk group | ||||
---|---|---|---|---|---|---|
Short interval | Long interval |
P
| Short interval | Long interval |
P
| |
Patients | 65 | 25 | 79 | 21 | ||
Relapse location (%) | 0.868 | 0.383 | ||||
Local | 26 (40.6) | 11 (44.0) | 29 (37.2) | 5 (23.8) | ||
Intrahepatic distant | 37 (57.8) | 14 (56.0) | 47 (60.3) | 15 (71.4) | ||
Extrahepatic | 1.0 (1.6) | 0.0 (0.0) | 2 (2.6) | 1 (4.8) | ||
Intrahepatic tumor number | 1.0 (1.0) | 1.5 (1.0) | 0.811 | 1.0 (1.0) | 2.0 (1.0) | 0.229 |
Intrahepatic tumor size (cm) | 1.7 (1.5) | 1.9 (1.9) | 0.718 | 1.9 (1.5) | 1.6 (1.3) | 0.797 |
Curative intent (%) | 44.0 (77.2) | 18.0 (81.8) | 0.886 | 43 (64.2) | 6 (37.5) | 0.087 |
BCLC (%) | 0.172 | 0.028 | ||||
0 | 19 (29.2) | 6 (24.0) | 15 (19.0) | 2 (9.5) | ||
A | 35 (53.8) | 12 (48.0) | 46 (58.2) | 10 (47.6) | ||
B | 7 (10.8) | 5 (20.0) | 8 (10.1) | 3 (14.3) | ||
C & D | 4 (6.2) | 2 (8.0) | 10 (12.7) | 6 (28.6) |